Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?

Blood Cancer J. 2014 Jun 27;4(6):e221. doi: 10.1038/bcj.2014.42.

Authors

Affiliations

¹ Laboratory for Molecular Biology and Tumor Cytogenetics, Department of Internal Medicine, Hospital Barmherzige Schwestern Linz, Linz, Austria.
² Department of Hematology, Stemcell-Transplantation, Hemostaseology and Oncology, Elisabethinen Hospital, Linz, Austria.
³ Department of Internal Medicine, Linz, Hospital Barmherzige Schwestern Linz, Austria.
⁴ B and S Central Laboratory, Linz, Austria.

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Base Sequence
Female
Humans
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / genetics*
Molecular Sequence Data
Mutation*
Neoplasm Recurrence, Local / genetics*
Neoplasms, Second Primary / genetics*
Nuclear Proteins / genetics*
Nucleophosmin

Substances

NPM1 protein, human
Nuclear Proteins
Nucleophosmin